Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways

被引:187
作者
Barlow, C
Brown, KD
Deng, CX
Tagle, DA
WynshawBoris, A
机构
[1] NIDDKD,LAB GENET DIS RES,NATL HUMAN GENOME RES INST,NIH,BETHESDA,MD 20892
[2] NIDDKD,LAB GENE TRANSFER,NATL HUMAN GENOME RES INST,NIH,BETHESDA,MD 20892
[3] NIDDKD,BIOCHEM & METAB LAB,NIH,BETHESDA,MD 20892
关键词
D O I
10.1038/ng1297-453
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Atm is part of a pathway that responds to DNA damage from ionizing radiation (IR). This pathway involves p53, as Atm-deficient cell lines and mice are defective in p53 induction after IR1-5. p53 is a multi-functional protein that simultaneously regulates distinct downstream pathways controlling cell-cycle progression and apoptosis(6,7). However, the mechanisms by which p53 differentially activates downstream pathways are unknown. To determine the relationship between Atm and p53, we examined cell-cycle and apoptotic responses in Atm-, p53- (ref. 8) and p21-deficient(9) mice after IR in the whole animal, As expected, p53 protein levels were not induced by IR in thymus of Atm-deficient mice. IR-induced cell-cycle checkpoint function was also defective, and induction of p21 was attenuated in thymus from Atm-deficient mice, However, IR-induced apoptosis and Bar induction were completely normal; both of which are mediated by p53. IR-induced thymic apoptosis was suppressed in Atm/p53 double-mutant mice but not in Atm/p21 double mutants, demonstrating p53 dependence and Atm independence. Thus, Atm deficiency results in lack of p53 induction by IR, but only selective disruption of p53-dependent functions, Our results support a model in which upstream effecters such as Atm selectively activate p53 to regulate specific downstream pathways, providing a mechanism for controlling distinct cell-cycle and apoptotic responses.
引用
收藏
页码:453 / 456
页数:4
相关论文
共 31 条
  • [1] [Anonymous], 1988, Antibodies: A Laboratory Manual
  • [2] Atm-deficient mice: A paradigm of ataxia telangiectasia
    Barlow, C
    Hirotsune, S
    Paylor, R
    Liyanage, M
    Eckhaus, M
    Collins, F
    Shiloh, Y
    Crawley, JN
    Ried, T
    Tagle, D
    WynshawBoris, A
    [J]. CELL, 1996, 86 (01) : 159 - 171
  • [3] Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation
    Baskaran, R
    Wood, LD
    Whitaker, LL
    Canman, CE
    Morgan, SE
    Xu, Y
    Barlow, C
    Baltimore, D
    WynshawBoris, A
    Kastan, MB
    Wang, JYJ
    [J]. NATURE, 1997, 387 (6632) : 516 - 519
  • [4] The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage
    Brown, KD
    Ziv, Y
    Sadanandan, SN
    Chessa, L
    Collins, FS
    Shiloh, Y
    Tagle, DA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 1840 - 1845
  • [5] RADIATION-INDUCED CELL-CYCLE ARREST COMPROMISED BY P21 DEFICIENCY
    BRUGAROLAS, J
    CHANDRASEKARAN, C
    GORDON, JI
    BEACH, D
    JACKS, T
    HANNON, GJ
    [J]. NATURE, 1995, 377 (6549) : 552 - 557
  • [6] The product of the ATM gene is a 370-kDa nuclear phosphoprotein
    Chen, G
    Lee, EYHP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (52) : 33693 - 33697
  • [7] p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells
    Chen, XB
    Ko, LJ
    Jayaraman, L
    Prives, C
    [J]. GENES & DEVELOPMENT, 1996, 10 (19) : 2438 - 2451
  • [8] THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS
    CLARKE, AR
    PURDIE, CA
    HARRISON, DJ
    MORRIS, RG
    BIRD, CC
    HOOPER, ML
    WYLLIE, AH
    [J]. NATURE, 1993, 362 (6423) : 849 - 852
  • [9] MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL
    DENG, CX
    ZHANG, PM
    HARPER, JW
    ELLEDGE, SJ
    LEDER, P
    [J]. CELL, 1995, 82 (04) : 675 - 684
  • [10] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825